Dr Owen O'Connor is a recipient of the American Cancer Society Research Professorship, the most prestigious award made by the American Cancer Society, a Professor of Medicine and Experimental Therapeutics, and the Director of the Center for Lymphoid in the Herbert Irving Comprehensive Cancer Center at Columbia University Medical centre.
Over the past two decades, Dr O'Connor has become an international authority on the management of Hodgkin Lymphoma and non-Hodgkin lymphoma, as well as the development of novel drugs for the treatment of these diseases. To date, he has pioneered the development of four new drugs approved for the treatment of lymphoma and collaborated with national and international colleagues on many others. He has been named on nearly 30 patents on new drugs and methods to treat cancer, which led to his induction into the New Jersey Society of Inventors Hall of Fame in 2016. He is also recognized as among the Top 50 Irish Americans in Science and Medicine by the government of Ireland.
Dr O'Connor received his PhD in Biochemistry and Toxicology from the New York University School of Medicine and his MD from The University of Medicine and Dentistry of New Jersey. He completed his residency in Internal Medicine at the New York-Presbyterian Hospital at Cornell University Medical Center and did his fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center.Back to speakers